Skip to main navigation Skip to search Skip to main content

Combining VPS34 inhibitors with STING agonists enhances type I interferon signaling and anti-tumor efficacy

  • Yasmin Yu*
  • , Madhumita Bogdan
  • , Muhammad Zaeem Noman
  • , Santiago Parpal
  • , Elisabetta Bartolini
  • , Kris Van Moer
  • , Simone Caroline Kleinendorst
  • , Kristine Bilgrav Saether
  • , Lionel Trésaugues
  • , Camilla Silvander
  • , Johan Lindström
  • , Jodi Simeon
  • , Mary Jane Timson
  • , Hikmat Al-Hashimi
  • , Bryan D. Smith
  • , Daniel L. Flynn
  • , Andrey Alexeyenko
  • , Jenny Viklund
  • , Martin Andersson
  • , Jessica Martinsson
    • Katja Pokrovskaja Tamm, Angelo De Milito, Bassam Janji*
*Corresponding author for this work

Research output: Contribution to journal › Article › Research › peer-review

12 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Combining VPS34 inhibitors with STING agonists enhances type I interferon signaling and anti-tumor efficacy'. Together they form a unique fingerprint.
Sort by

Biochemistry, Genetics and Molecular Biology

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology

Keyphrases